InvestorsHub Logo
Followers 37
Posts 6637
Boards Moderated 3
Alias Born 05/06/2014

Re: None

Friday, 11/05/2021 6:35:02 AM

Friday, November 05, 2021 6:35:02 AM

Post# of 486
Reason for move yesterday:

Merck had malnupiravir approved in the UK. According to the study below, it’s efficacy is substantially improved when combined with favipiravir (Avigan) which ADXT is about to acquire with merger.

"with a combination of favipiravir and molnupiravir suggest that the combination has significantly greater antiviral activity than either drug alone with SARS-CoV-2."

Binding agreement was announced on 10/5/2021 for favipiravir (Avigan.

AiPharma Signs Binding Agreement To Sell To Aditxt Inc (Nasdaq: ADTX). AiPharma Is The Rights Holder Of Antiviral Tablet Avigan / Reeqonus / Qifenda That Has Treated Over 1.5M COVID-19 Patients Since The Outbreak.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADTX News